Richard Furie, MD

Richard Furie, MD, is Chief of the Division of Rheumatology at Northwell Health.

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

ByLuke Halpern, Assistant Editor,Richard Furie, MD

March 11th 2025

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

ByLuke Halpern, Assistant Editor,Richard Furie, MD

March 4th 2025

Obinutuzumab is effective in reducing proteinuria and preserving kidney function in lupus nephritis, with consistent benefits across high-disease activity subgroups.

Richard Furie, MD

Articles by Richard Furie, MD

Insights: Obinutuzumab Faces Integration Challenges, Long-Term Potential in Lupus Nephritis

Expert: Obinutuzumab Shows Promise in Lupus Nephritis, Reinforcing Role in High-Disease Patients

Latest Updated Articles

Trending on Pharmacy Times

Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases

Measles On the Rise: Global Surge and US Status at Risk

November 2025 Trending Products

FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer

FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer